Docetaxel serum protein binding with high affinity to alpha1-acid glycoprotein

Investigational New Drugs

Volumn 14, Issue 2, 1996, Pages 147-151

  Urien, Saïk ^a   Barré, Jérôme ^a   Morin, Christophe ^a   Paccaly, Anne ^b   Montay, Guy ^b   Tillement, Jean Paul ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b SANOFI   (France)

Author keywords

Docetaxel; Plasma binding; Protein binding

Indexed keywords

ALBUMIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; LIPOPROTEIN; OROSOMUCOID; PLASMA PROTEIN; VINBLASTINE;

ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ERYTHROCYTE; HUMAN; HUMAN CELL; NORMAL HUMAN; PH; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0029800979     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00210785     Document Type: Article

References (13)

1. Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN: The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®). Cancer Treatment Rev 19:351-386, 1993
2. Bruno R, Sanderink GJ: Pharmacokinetics and metabolism of Taxotere (Docetaxel). Cancer Surveys 17:305-313, 1993
3. Bruno R, Hille D, Thomas L, Riva A, Sheiner L: Population pharmacokinetic/pharmacodynamic (PK/PD) studies of docetaxel (Taxotere®) in phase II studies. Proc Am Soc Clin Oncol 14:457, 1995
4. Routledge PA: The plasma protein binding of basic drugs. Br J Clin Pharmacol 22:499-506, 1986
5. Tillement JP, Houin G, Zini R, Urien S, Albengres E, Barré J, Lecomte M, D'Ahis P, Sébille B: The binding of drugs to biological macromolecules in plasma. Recent advances and therapeutic significance. Adv Drug Res 13:59-94, 1984
6. Havel RJ, Eder HA, Bragton JM: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1354, 1955
7. Urien S, Riant P, Renouard A, Coulomb A, Rocher I, Tillement JP: Binding of indapamide to serum proteins and erythrocytes. Biochem Pharmacol 37:2963-2966, 1988
8. Urien S: MicroPharm. A software designed to analyse pharmacological data from kinetic, binding and tissue extraction experiments. Bull Cancer 78:654, 1991
9. 1-acid glycoprotein concentrations in health. Br J Clin Pharmacol 20:500-502, 1985
10. 1-acid glycoprotein. Clin Pharmacol Ther 32:652-658, 1982
11. 1-acid glycoprotein, albumin and nonesterified fatty acids in serum binding of apazone and warfarin. Clin Pharmacol Ther 39:683-689, 1986
12. 1-acid glycoprotein. Res Commun Chem Pathol Pharmacol 80:337-344, 1993
13. 1-acid Glycoprotein. Genetics, Biochemistry, Physiological Functions and Pharmacology. Alan R. Liss, Inc., New York, 1989, pp 337-350